e-Drug3D

830

AMINOLEVULINIC ACID


INN
AMINOLEVULINIC ACID

cas 106-60-5
CLASS

ANTINEOPLASTIC
DERMATOLOGIC
CHEMOPHOTODYNAMIC
PHOTOSENSITIZING AGENTS
A PORPHYRIN PRECURSOR
TREATMENT OF MINIMALLY TO MODERATELY THICK ACTINIC KERATOSES OF THE FACE OR SCALP
MALIGNANT GLIOMA (DRUG FOR RARE DISEASE IN EUROPE)

ROUTE (list)

TOPICAL ORAL

ATC code

L01XD04

PK parameters

F 55 PERCENT
t1/2 0.7 HOUR

Solubility

VERY SOLUBLE IN WATER


Target

-

PDB
6HZP (CRYSTAL STRUCTURE OF A POT FAMILY TRANSPORTER IN COMPLEX WITH 5-AMINOLEVULINIC ACID)

Ligand code = FVT (link to the list of PDB complexes)

Download experimental 3D coordinates of FVT with added hydrogens

DrugCentral

Unknown

Download SDF file 5-amino-4-oxopentanoic acid

Formula:
C5H9NO3

Calculated chemical properties:

MW 130.12
NB_atoms 9
XLogP -1.96
PSA 76.587
NB_HD 2
NB_HA 4
fsp3 0.60
Lipinski(0=no;1=yes) 1

FDA
NDA 020965 (label) INN (AMINOLEVULINIC ACID HYDROCHLORIDE) LEVULAN (SUN PHARM INDS INC) APPROVAL= AP YEAR= 1999 NEWMOLECULARENTITY
NDA 208081 (label) INN (AMINOLEVULINIC ACID HYDROCHLORIDE) AMELUZ (BIOFRONTERA) APPROVAL= AP YEAR= 2016
NDA 208630 (label) INN (AMINOLEVULINIC ACID HYDROCHLORIDE) GLEOLAN (NXDC) APPROVAL= AP YEAR= 2017

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL